Advertisement
MedPage Today

Gene Therapy Supply Runs Out, Company Warns of Treatment Delays

HealthDaily Composite

(MedPage Today) -- Etranacogene dezaparvovec (Hemgenix), the only commercially available gene therapy for hemophilia B, is temporarily unavailable, according to maker CSL Behring. In a letter addressed to the hemophilia B community, the company...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement